Evaluation of intraperitoneal vincristine in malignant peritoneal effusion

K. L. Bairy, S. Sanath, G. C. Jagetia, S. N. Somayaji, M. S. Vidyasagar, M. S. Baliga

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The efficacy and safety of intraperitoneal administration of vincristine sulphate was determined in mice bearing Ehrlich ascitic carcinoma. The tumor bearing animals were administered with 0.5 mg/kg body weight (b.wt) of freshly prepared vincristine sulphate intraperitoneally on day 6 after tumor transplantation followed by drug administration once daily 5 days a week consecutively. The observations regarding the survival, alteration in the volume of peritoneal fluid, increase in life span and pathological changes in the liver, kidney, gastrointestinal tract and bone tissues were made. The vincristine sulphate treatment reduced the malignant cell population significantly and there were no significant changes in the histological picture of liver, kidney, bone, except the intestine, where atropy of villi demonstrating nests and cords of uniform small round cells were observed. Our experimental data suggests that intraperitoneal administration of vincristine is beneficial in malignant peritoneal effusion.

Original languageEnglish
Pages (from-to)270-278
Number of pages9
JournalIndian Journal of Physiology and Pharmacology
Volume47
Issue number3
Publication statusPublished - 01-01-2003

Fingerprint

Ascitic Fluid
Vincristine
Kidney
Bone and Bones
Liver
Intestines
Gastrointestinal Tract
Neoplasms
Transplantation
Body Weight
Carcinoma
Safety
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Physiology
  • Pharmacology
  • Physiology (medical)

Cite this

Bairy, K. L., Sanath, S., Jagetia, G. C., Somayaji, S. N., Vidyasagar, M. S., & Baliga, M. S. (2003). Evaluation of intraperitoneal vincristine in malignant peritoneal effusion. Indian Journal of Physiology and Pharmacology, 47(3), 270-278.
Bairy, K. L. ; Sanath, S. ; Jagetia, G. C. ; Somayaji, S. N. ; Vidyasagar, M. S. ; Baliga, M. S. / Evaluation of intraperitoneal vincristine in malignant peritoneal effusion. In: Indian Journal of Physiology and Pharmacology. 2003 ; Vol. 47, No. 3. pp. 270-278.
@article{601436ec189a409c9c99b8c54e247a09,
title = "Evaluation of intraperitoneal vincristine in malignant peritoneal effusion",
abstract = "The efficacy and safety of intraperitoneal administration of vincristine sulphate was determined in mice bearing Ehrlich ascitic carcinoma. The tumor bearing animals were administered with 0.5 mg/kg body weight (b.wt) of freshly prepared vincristine sulphate intraperitoneally on day 6 after tumor transplantation followed by drug administration once daily 5 days a week consecutively. The observations regarding the survival, alteration in the volume of peritoneal fluid, increase in life span and pathological changes in the liver, kidney, gastrointestinal tract and bone tissues were made. The vincristine sulphate treatment reduced the malignant cell population significantly and there were no significant changes in the histological picture of liver, kidney, bone, except the intestine, where atropy of villi demonstrating nests and cords of uniform small round cells were observed. Our experimental data suggests that intraperitoneal administration of vincristine is beneficial in malignant peritoneal effusion.",
author = "Bairy, {K. L.} and S. Sanath and Jagetia, {G. C.} and Somayaji, {S. N.} and Vidyasagar, {M. S.} and Baliga, {M. S.}",
year = "2003",
month = "1",
day = "1",
language = "English",
volume = "47",
pages = "270--278",
journal = "Indian Journal of Physiology and Pharmacology",
issn = "0019-5499",
publisher = "Association of Physiologists and Pharmacologists of India",
number = "3",

}

Bairy, KL, Sanath, S, Jagetia, GC, Somayaji, SN, Vidyasagar, MS & Baliga, MS 2003, 'Evaluation of intraperitoneal vincristine in malignant peritoneal effusion', Indian Journal of Physiology and Pharmacology, vol. 47, no. 3, pp. 270-278.

Evaluation of intraperitoneal vincristine in malignant peritoneal effusion. / Bairy, K. L.; Sanath, S.; Jagetia, G. C.; Somayaji, S. N.; Vidyasagar, M. S.; Baliga, M. S.

In: Indian Journal of Physiology and Pharmacology, Vol. 47, No. 3, 01.01.2003, p. 270-278.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of intraperitoneal vincristine in malignant peritoneal effusion

AU - Bairy, K. L.

AU - Sanath, S.

AU - Jagetia, G. C.

AU - Somayaji, S. N.

AU - Vidyasagar, M. S.

AU - Baliga, M. S.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - The efficacy and safety of intraperitoneal administration of vincristine sulphate was determined in mice bearing Ehrlich ascitic carcinoma. The tumor bearing animals were administered with 0.5 mg/kg body weight (b.wt) of freshly prepared vincristine sulphate intraperitoneally on day 6 after tumor transplantation followed by drug administration once daily 5 days a week consecutively. The observations regarding the survival, alteration in the volume of peritoneal fluid, increase in life span and pathological changes in the liver, kidney, gastrointestinal tract and bone tissues were made. The vincristine sulphate treatment reduced the malignant cell population significantly and there were no significant changes in the histological picture of liver, kidney, bone, except the intestine, where atropy of villi demonstrating nests and cords of uniform small round cells were observed. Our experimental data suggests that intraperitoneal administration of vincristine is beneficial in malignant peritoneal effusion.

AB - The efficacy and safety of intraperitoneal administration of vincristine sulphate was determined in mice bearing Ehrlich ascitic carcinoma. The tumor bearing animals were administered with 0.5 mg/kg body weight (b.wt) of freshly prepared vincristine sulphate intraperitoneally on day 6 after tumor transplantation followed by drug administration once daily 5 days a week consecutively. The observations regarding the survival, alteration in the volume of peritoneal fluid, increase in life span and pathological changes in the liver, kidney, gastrointestinal tract and bone tissues were made. The vincristine sulphate treatment reduced the malignant cell population significantly and there were no significant changes in the histological picture of liver, kidney, bone, except the intestine, where atropy of villi demonstrating nests and cords of uniform small round cells were observed. Our experimental data suggests that intraperitoneal administration of vincristine is beneficial in malignant peritoneal effusion.

UR - http://www.scopus.com/inward/record.url?scp=0038711431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038711431&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 270

EP - 278

JO - Indian Journal of Physiology and Pharmacology

JF - Indian Journal of Physiology and Pharmacology

SN - 0019-5499

IS - 3

ER -